2179.4000 -41.20 (-1.86%)
NSE Sep 11, 2026 15:31 PM
Volume: 1.1M
 

logo
Wockhardt Ltd.
29 May 2026
2179.40
-1.86%
Business Standard
The buying on the counter came after the company received approval from the CDSCO for the import and marketing of Zaynich Zidebactam/Cefepime
Promoters unpledged 4.14% of shares in last quarter. Total pledge stands at 14.68% of promoter holdings
More from Wockhardt Ltd.
All earning calls
Investor presentations from Wockhardt Ltd.
All investor presentations